An increasing body of evidence indicates that the Epidermal Growth Factor Receptor (EGFR) pathway plays a role in the activation of the AR within GBM cells, as AR activation may also occur via ligand-independent signaling through the EGFR [14]. The gene discussed is EGFR; the disease is glioblastoma.